Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
VB JAPAN TECHNOLOGY CO., LTD. is active in the Biotechnology & Pharmaceuticals technology area with a focused set of pending matters. The portfolio contains 1 pending office action, which is currently assigned to 1 distinct examiner. This activity is confined to 1 distinct art unit, indicating a specialized area of research and development that is currently undergoing formal review. This level of focus is common for companies targeting specific pharmaceutical or biotechnological breakthroughs.
The busiest examiner for the portfolio is KASSA, TIGABU, who is handling 1 busiest examiner pending action. This action represents the full extent of the company's 1 pending office action total. For practitioners, this means that the immediate success of the company's prosecution in the biotechnology sector relies on the outcomes generated by this examiner within the identified art unit. The alignment of the pending action with the distinct examiner and art unit simplifies the tracking of the company's current patenting progress.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KASSA, TIGABU | 1 | 36.7% | +27.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691949 | ANTI-AGING AGENT, COSMETIC PRODUCT, WET TOWEL, AND HYGIENE PRODUCT | KASSA, TIGABU | 4d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691949 | ANTI-AGING AGENT, COSMETIC PRODUCT, WET TOWEL, AND HYGIENE PRODUCT | KASSA, TIGABU | 4d overdue |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18691949 | ANTI-AGING AGENT, COSMETIC PRODUCT, WET TOWEL, AND HYGIENE PRODUCT | KASSA, TIGABU | 1619 | §102§103 | Non-Final OA | 4d overdue | Pending | Mar 14, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial